KLRS
Kalaris Therapeutics, Inc.
+0.05 (+1.57%)3.23USD19.2K成交股數76.9M市值–本益比(近四季)466.0股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 9.0M | 7.6M | 7.2M | 9.1M | 8.4M | 6.0M | 36.0M | 100K | 3.2M | 2.0M | 33.4M | 34.2M |
| 銷售管理費用 | 3.4M | 4.3M | 3.6M | 3.6M | 3.8M | 4.3M | 1.8M | – | 976K | 602K | 10.5M | 12.8M |
| 營業利益 | −12.4M+1% | −11.8M+14% | −10.8M-71% | −12.7M | −12.3M+193% | −10.4M+304% | −37.8M-39% | – | −4.2M | −2.6M | −62.4M | −47.0M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −11.5M+1% | −10.9M+6% | −10.0M-74% | −11.9M | −11.4M+101% | −10.2M+199% | −38.1M-36% | – | −5.7M | −3.4M | −59.7M | −44.3M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.48-21% | -0.46-82% | 0.92-103% | -0.64 | -0.61-86% | -2.52-3% | -28.16-31% | – | -4.26 | -2.60 | -40.78 | -0.39 |
| 稀釋股數 | 23.8M | 23.7M | 15.3M | 18.7M | 18.7M | 4.1M | 1.4M | – | 1.3M | 1.3M | 4.5M | 114M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 43.2M | 34.4M | 98.1M | 42.4M | 88.4M | 101M | 1.9M | – | 6.2M | 5.2M | 90.1M | 95.6M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 99.5M | 110M | 122M | 81.2M | 92.8M | 103M | 123M | – | 131M | 144M | 191M | 248M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 41.9M | 41.2M | 42.9M | 39.3M | 39.7M | 39.2M | 1.4M | – | 10.7M | 23.7M | 45.0M | 53.0M |
| 股東權益 | 57.7M | 68.6M | 78.8M | 41.9M | 53.1M | 63.9M | −89.4M | – | −51.5M | −47.5M | −45.0M | 195M |
| 負債比 | 42.1% | 37.6% | 35.3% | 48.4% | 42.8% | 38.0% | 1.2% | – | 8.2% | 16.4% | 23.6% | 21.3% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −11.6M+56% | – | – | – | −7.4M+65% | – | – | – | −4.5M | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −43.4M | –% | -2.85 | −38.6M |
| FY2024 | – | – | −69.2M | –% | -51.77 | – |
| FY2023 | – | – | −190M | –% | -42.09 | – |
| FY2022 | – | – | −169M | –% | -2.20 | – |
| FY2021 | – | – | −172M | –% | -2.74 | −106M |
| FY2020 | – | – | −69.8M | –% | -2.59 | −61.0M |
| FY2019 | 165K | – | −23.8M | -14,447.9% | -18.54 | −20.5M |